| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.14 | 0.7 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |